You expect Nader to put the worst spin on things? Everyone knows he's overoptimistic in general. He's not a glass half full kind of guy, he's of the opinion that the glass is always full. As long as the company is making progress like it has been lately it's no big deal. He knows what needs to be done and what order to do it and is taking into consideration things that are important for the company's long term success. Unlike the 13d who's plan is a disaster waiting to happen. You can tell it's something they took little thought in.

Anyone that's been here for any length of time knows the massive potential of leronlimab. It's taking longer than expected, so be it. The end results will be worth the long ride.

I have to say there are quite a few whiners who own or owned this stock. This isn't Tesla this is a biotech stock if you don't know the risk/reward/time of biotech then you shouldn't dabble. When I switched over to biotech's in 2018 I had a decent idea of all three. I still got walloped with VSTM and was down a little on two others but I didn't cry about it I just found a better stock which was Cytodyn.